Actively Recruiting
CT-guided Lung Biopsy Risk Optimization Method
Led by Insel Gruppe AG, University Hospital Bern · Updated on 2026-02-02
198
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.
CONDITIONS
Official Title
CT-guided Lung Biopsy Risk Optimization Method
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to provide informed consent (knowledge of project languages), >18 years
- Indeterminate or suspicious lung lesion unsuitable for transbronchial biopsy or status after unsuccessful transbronchial biopsy
- Indication for biopsy given by referring specialist
You will not qualify if you...
- Preintervention bleeding into the pleural cavity
- More than 1 lesion should be biopsied at the same time
- Infiltration of the thoracic wall
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10
Bern, Switzerland, 3010
Actively Recruiting
Research Team
M
Michael Brönnimann, MD
CONTACT
J
Johannes Heverhagen, Prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here